Introduction:

drug consumption has increased in the last decades and precisely pregnancy represents a situation of maximum risk related to its use.

Objective:

to describe maternal factors and drug consumption during pregnancy associated with the appearance of neonatal alterations.

Methods:

a retrospective longitudinal descriptive study was conducted in the period from September 2015 to September 2018 to describe maternal factors and medication consumption during pregnancy associated with the appearance of neonatal alterations. The study population consisted of 779 pregnant women recruited during this period and the sample consisted of 518 randomly selected pregnant women. We worked with two groups: one group of pregnant women who did not consume drugs during pregnancy and the other who did. The data obtained made it possible to analyze maternal variables such as the consumption of drugs during pregnancy, the area of origin of those who consumed them, the drugs prescribed or not and the trimester of pregnancy in which they were consumed and, for the newborn, the presence or absence of neonatal alterations.

Results:

the frequency of medication consumption during pregnancy was 55.21%.

Conclusions:

in the sample studied, the consumption of drugs during pregnancy prevailed, mainly in the first trimester, mostly by self-medication in women from rural areas, and neonatal alterations were significantly associated with all the above mentioned.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )